225 related articles for article (PubMed ID: 33660581)
1. Serum Based miRNA as a Diagnostic Biomarker for Multiple Sclerosis: a Systematic Review and Meta-Analysis.
Zailaie SA; Siddiqui JJ; Al Saadi RM; Anbari DM; S Alomari A; Cupler EJ
Immunol Invest; 2022 May; 51(4):947-962. PubMed ID: 33660581
[TBL] [Abstract][Full Text] [Related]
2. Analysis of potential microRNA biomarkers for multiple sclerosis.
Al-Temaimi R; Alshammari N; Alroughani R
Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
[TBL] [Abstract][Full Text] [Related]
4. MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.
Zanghì A; Manuti V; Serviddio G; D'Amico E; Avolio C
Front Immunol; 2023; 14():1226130. PubMed ID: 37711630
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
[TBL] [Abstract][Full Text] [Related]
7. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
Sharaf-Eldin WE; Kishk NA; Gad YZ; Hassan H; Ali MAM; Zaki MS; Mohamed MR; Essawi ML
J Neurol Sci; 2017 Dec; 383():188-198. PubMed ID: 29246612
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
Stilund M; Gjelstrup MC; Petersen T; Møller HJ; Rasmussen PV; Christensen T
PLoS One; 2015; 10(4):e0119681. PubMed ID: 25860354
[TBL] [Abstract][Full Text] [Related]
9. miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
Muñoz-San Martín M; Gómez I; Quiroga-Varela A; Gonzalez-Del Río M; Robles Cedeño R; Álvarez G; Buxó M; Miguela A; Villar LM; Castillo-Villalba J; Casanova B; Quintana E; Ramió-Torrentà L
Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36724195
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls.
Keller A; Leidinger P; Lange J; Borries A; Schroers H; Scheffler M; Lenhof HP; Ruprecht K; Meese E
PLoS One; 2009 Oct; 4(10):e7440. PubMed ID: 19823682
[TBL] [Abstract][Full Text] [Related]
11. Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.
Keller A; Leidinger P; Meese E; Haas J; Backes C; Rasche L; Behrens JR; Pfuhl C; Wakonig K; Gieß RM; Jarius S; Meder B; Bellmann-Strobl J; Paul F; Pache FC; Ruprecht K
J Neuroinflammation; 2015 Oct; 12():196. PubMed ID: 26521232
[TBL] [Abstract][Full Text] [Related]
12. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
[No Abstract] [Full Text] [Related]
13. A Meta-Analytic Review of the Value of miRNA for Multiple Sclerosis Diagnosis.
Zhou Z; Xiong H; Xie F; Wu Z; Feng Y
Front Neurol; 2020; 11():132. PubMed ID: 32158427
[No Abstract] [Full Text] [Related]
14. Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.
Arisi I; Malimpensa L; Manzini V; Brandi R; Gosetti di Sturmeck T; D'Amelio C; Crisafulli S; Ferrazzano G; Belvisi D; Malerba F; Florio R; Pascale E; Soreq H; Salvetti M; Cattaneo A; D'Onofrio M; Conte A
Front Immunol; 2023; 14():1234869. PubMed ID: 38152407
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-22 Level in Patients with Multiple Sclerosis and Its Relationship with Vitamin D and Vitamin D Receptor Levels.
Khedr AMB; Shaker OG; Hassan A; Hussein M; Kamal YS; Azouz TA
Neuroimmunomodulation; 2022; 29(2):128-134. PubMed ID: 34537762
[TBL] [Abstract][Full Text] [Related]
16. Association between miRNA-145 and miRNA-155 expression in peripheral blood mononuclear cells of patients with multiple sclerosis: a case-control study.
Ali Ashrafi S; Asadi M; Shanehbandi D; Sadigh Eteghad S; Fazlollahi A; Nejadghaderi SA; Shaafi S
BMC Neurol; 2022 Nov; 22(1):405. PubMed ID: 36329419
[TBL] [Abstract][Full Text] [Related]
17. Potential Value of miR-23a for Discriminating Neuromyelitis Optica Spectrum Disorder from Multiple Sclerosis.
Sharaf-Eldin W; Kishk N; Sakr B; El-Hariri H; Refeat M; ElBagoury N; Essawi M
Arch Iran Med; 2020 Oct; 23(10):678-687. PubMed ID: 33107309
[TBL] [Abstract][Full Text] [Related]
18. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
19. Differential microRNA expression in blood in multiple sclerosis.
Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
